New surgical experience

VSY Biotechnology GmbH has launched Protectalon Duo.

New surgical experience
Colin Kerr
Colin Kerr
Published: Monday, February 1, 2021
Protectalon Duo
VSY Biotechnology GmbH has launched Protectalon Duo “Protectalon DUO Kit demonstrates VSY’s commitment to Ophthalmic Surgery Eye Care Professionals and will help to meet their OVD needs at different stages of cataract surgery with a single kit. It is available now for safe, fast and smooth surgery,” said a company spokesperson. Protectalon DUO is a dual pack containing high filling volume of one unit cohesive (14mg/mL, 1.1mL) and one unit dispersive (30mg/ml, 1.1ml) NaHA-based OVDs, providing reliable anterior chamber maintenance with exceptional cohesivity and superior endothelial cell protection, according to VSY. The product has CE and it is now available in Europe, said the spokesperson. “VSY Biotechnology GmbH is an innovation-driven company with its progressive R&D activities in ophthalmology, orthopaedics, aesthetics and biotechnologic drugs. VSY Biotechnology focuses on developing, designing and manufacturing superior, state-of-the-art products to serve doctors, patients and consumers beyond their expectations,” he said. www.vsybiotechnology.com
Tags: VSY Protectalon
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...